You have 9 free searches left this month | for more free features.

p53

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Trial in Houston (SGT-53, Topotecan, Cyclophosphamide)

Suspended
  • Neoplasm
  • SGT-53
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • Sodium stibogluconate
  • Guangzhou, Guangdong, China
    First Affiliated Hospital of Jinan University
Jun 5, 2021

Metastatic Pancreatic Cancer Trial in Dallas (SGT-53, nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Cancer
  • SGT-53
  • +2 more
  • Dallas, Texas
    Mary Crowley Cancer Research Center
Feb 7, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)

Active, not recruiting
  • Carcinoma, Squamous Cell
  • +2 more
  • Intensity Modulated Radiotherapy (IMRT) - deintensified
  • +4 more
  • Gainesville, Florida
  • +3 more
Jan 25, 2022

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Endometrial Cancer, Serous Tumor, P53 Mutation Trial in Toronto (Cisplatin, External Beam Radiation, Carboplatin)

Recruiting
  • Endometrial Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2021

High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

Completed
  • High-grade Serous Ovarian Cancer
  • APR-246
  • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
  • Gent, Belgium
  • +11 more
Jul 19, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Chicago, Illinois
    Northwestern University
Oct 13, 2021

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)

Recruiting
  • Refractory Solid Tumors
  • Arsenic trioxide
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
May 11, 2021

Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

Recruiting
  • Malignant Salivary Gland Cancer
  • Salivary Gland Cancer
  • Tampa, Florida
  • +2 more
Feb 10, 2022

Arsenic Trioxide, p53 Mutations, Refractory Cancer Trial in Shanghai (Arsenic Trioxide)

Recruiting
  • Arsenic Trioxide
  • +3 more
  • Arsenic Trioxide
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Jan 4, 2021

Colorectal Carcinoma, Ulcerative Colitis Trial in Chicago (Atorvastatin Calcium, Biospecimen Collection, Placebo Administration)

Recruiting
  • Colorectal Carcinoma
  • Ulcerative Colitis
  • Atorvastatin Calcium
  • +2 more
  • Chicago, Illinois
    Northwestern University
Feb 10, 2022

Colorectal Cancer Metastatic, Colorectal Cancer Stage IV, TP53 Gene Mutation Trial in Bergen (Cyclophosphamide)

Terminated
  • Colorectal Cancer Metastatic
  • +2 more
  • Bergen, Norway
    Haukeland University Hospital
Jan 20, 2021

Short- and Medium-term Evaluation of Mastoid Filling Using

Not yet recruiting
  • Cholesteatoma
  • verre bioactif 45S5 GlassBONE
  • verre bioactif S53P4 Bonalive
  • Lyon, Pierre-Bénite, France
    Hôpital Lyon Sud
Jun 16, 2023

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and

Completed
  • Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
  • APR-246
  • Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
  • Los Angeles, California
  • +54 more
Sep 20, 2022

Ovarian Cancer, Peritoneal Cavity Cancer Trial in Dallas (Ad5CMV-p53 gene)

Completed
  • Ovarian Cancer
  • Peritoneal Cavity Cancer
  • Ad5CMV-p53 gene
  • Dallas, Texas
    Simmons Cancer Center - Dallas
Jan 29, 2021

Solid Tumor With p53 Wild Type Status Trial in Worldwide (CGM097)

Completed
  • Solid Tumor With p53 Wild Type Status
  • Boston, Massachusetts
  • +4 more
Jun 10, 2021

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)

Unknown status
  • Wilms Tumor
  • +2 more
  • P53, Ki67 and Cyclin A IHC.
  • Mansoura, Dakahlia, Egypt
    Mansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021

Oesophageal Carcinoma Trial in Australia (APR-246)

Terminated
  • Oesophageal Carcinoma
  • Clayton, Victoria, Australia
  • +4 more
Dec 10, 2021

Li Fraumeni Syndrome Trial in Villejuif (whole body MRI)

Completed
  • Li Fraumeni Syndrome
  • whole body MRI
  • Villejuif, France
    Institut Gustave Roussy
Feb 23, 2021

Schizophrenia Trial in Worldwide (DSP-5423P Placebo, DSP-5423P 40mg, DSP-5423P 80mg)

Completed
  • Schizophrenia
  • DSP-5423P Placebo
  • +4 more
  • Beijing, Etc., China
  • +7 more
Apr 9, 2022

Spine Fusion, Spinal Deformity Trial in Turku (S53P4 bioactive glass putty)

Active, not recruiting
  • Spine Fusion
  • Spinal Deformity
  • S53P4 bioactive glass putty
  • Turku, Finland
    Turku University Hospital Department of Neurosurgery
Aug 11, 2021